Table of Contents

• C F Verge,
• N J Howard,
• L Irwig,
• J M Simpson,
• D Mackerras,
• and M Silink

Environmental factors in childhood IDDM. A population-based, case-control study.

• T Danne,
• B Weber,
• R Hartmann,
• I Enders,
• W Burger,
• and G Hovener

Long-term glycemic control has a nonlinear association to the frequency of background retinopathy in adolescents with diabetes. Follow-up of the Berlin Retinopathy Study.

• M Mokan,
• A Mitrakou,
• T Veneman,
• C Ryan,
• M Korytkowski,
• P Cryer,
• and J Gerich

Hypoglycemia unawareness in IDDM.

• D Simmons,
• L M Shaw,
• D J Scott,
• T Kenealy,
• and R K Scragg

Diabetic nephropathy and microalbuminuria in the community. The South Auckland Diabetes Survey.

• G G Simoneau,
• J S Ulbrecht,
• J A Derr,
• M B Becker,
• and P R Cavanagh

Postural instability in patients with diabetic sensory neuropathy.

• E A McDaid,
• B Monaghan,
• A I Parker,
• J R Hayes,
• and J A Allen

Peripheral autonomic impairment in patients newly diagnosed with type II diabetes.

• S Suzuki,
• Y Hinokio,
• S Hirai,
• M Onoda,
• M Matsumoto,
• M Ohtomo,
• H Kawasaki,
• Y Satoh,
• H Akai,
• and K Abe

Diabetes with mitochondrial gene tRNALYS mutation.

• M S Hartwig,
• S S Cardoso,
• D K Hathaway,
• and A O Gaber

Reliability and validity of cardiovascular and vasomotor autonomic function tests.

• C Posadas-Romero,
• L Yamamoto-Kimura,
• I Lerman-Garber,
• J Zamora-Gonzalez,
• A Fajardo-Gutierrez,
• L Velazquez,
• and G Cardoso-Saldaãna

The prevalence of NIDDM and associated coronary risk factors in Mexico City.

• N A Lee and
• C A Reasner

Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM.

• N Ercan,
• M C Gannon,
• and F Q Nuttall

Effect of added fat on the plasma glucose and insulin response to ingested potato given in various combinations as two meals in normal individuals.

• M Berelowitz,
• C Fischette,
• W Cefalu,
• D S Schade,
• T Sutfin,
• and I A Kourides

Comparative efficacy of a once-daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM.

• S Suzuki,
• H Kawasaki,
• Y Satoh,
• M Ohtomo,
• M Hirai,
• A Hirai,
• S Hirai,
• M Onoda,
• M Matsumoto,
• and Y Hinokio

Urinary chiro-inositol excretion is an index marker of insulin sensitivity in Japanese type II diabetes.

• R J Barnard,
• T Jung,
• and S B Inkeles

Diet and exercise in the treatment of NIDDM. The need for early emphasis.

• K W Ko,
• S W Yang,
• and N H Cho

The incidence of IDDM in Seoul from 1985 to 1988.

• I M Holdaway,
• G D Gamble,
• G A Sanders,
• S C Greaves,
• E M Ellis-Pegler,
• and N Sharpe

Effect of fosinopril on cardiac and metabolic parameters in patients with NIDDM.

• L M Stone,
• S E Kahn,
• S S Deeb,
• W Y Fujimoto,
• and D Porte, Jr

Glucokinase gene variations in Japanese-Americans with a family history of NIDDM.

• A Ciavarella,
• A Mustacchio,
• C Ricci,
• M Capelli,
• and P Vannini

Enhanced pressor responsiveness to norepinephrine in type II diabetes. Effect of ACE inhibition.

• D Fava,
• R D Leslie,
• and P Pozzilli

Relationship between dairy product consumption and incidence of IDDM in childhood in Italy.

• R T Acton,
• J M Roseman,
• D S Bell,
• R L Goldenberg,
• M L Tseng,
• C Vanichanan,
• L A Harman,
• and R C Go

Genes within the major histocompatibility complex predict NIDDM in African-American women in Alabama.

• K L Miller and
• I B Hirsch

Physicians' practices in screening for the development of diabetic nephropathy and the use of glycosylated hemoglobin levels.

• A I Adler,
• E J Boyko,
• C D Schraer,
• and N J Murphy

Lower prevalence of impaired glucose tolerance and diabetes associated with daily seal oil or salmon consumption among Alaska Natives.

• R R Henry

Protein content of the diabetic diet.

• G C Weir,
• D M Nathan,
• and D E Singer

Standards of care for diabetes.

• S C Elbein,
• M D Hoffman,
• K L Bragg,
• and R A Mayorga

The genetics of NIDDM. An update.

• J A Marlett and
• T F Cheung

Dietary fiber guidelines in the Exchange Lists for Menu Planning. Should they be revised?

• H E Lebovitz

Stepwise and combination drug therapy for the treatment of NIDDM.

• M A Pfeifer and
• M P Schumer

Cardiovascular autonomic neuropathy. Where have we been and where are we going?

• H E Oppenheimer

There should be a national American Diabetes Association program for diabetes screening.

• J L Graner

Osler and his students. The "sweet pea" episode.

• S Zambon,
• G Baldo-Enzi,
• M Baiocchi,
• R Nosadini,
• E Manzato,
• and G Crepaldi

Lipoprotein(a) levels in type II diabetic patients are not influenced by metabolic control or by microalbuminuria.

• E Schober and
• G Granditsch

IDDM and celiac disease.

Unproven therapies. American Diabetes Association.

• Z T Bloomgarden

Diabetes and managed care.